News

Open Access to JRC Research Infrastructures - Three new calls launched for Training and Capacity Building

Published on
| 2 years ago
Programmes
  • Joint Research Center

The Joint Research Center (JRC), the European Commission’s science and knowledge service, has launched three new calls for the purposes of training and capacity building in its scientific laboratories and facilities to people working in academia and research organisations, small and medium enterprises (SMEs), and more in general to the public and private sector. More information on this initiative can be found here or in this JRC Brochure.

It concerns the following three calls:

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2068 articles available Browse all news
  • Research Infrastructures
  • Health
  • Digital, Industry & Space
  • Climate, Energy, Mobility

Lasers4EU 6th Transnational Access programme for laser research and innovation

The Lasers4EU project consortium of research infrastructures provides access to state-of-the-art laser technologies and services from primary and secondary laser sources to a wide range of laser-based instruments and techniques at 27 leading laser research institutions across Europe. More information is available in their mission and on the...

Read more
  • Research Infrastructures
  • Digital, Industry & Space
  • Climate, Energy, Mobility

Ready-PV first call for Transnational and Virtual Access to Advanced PV Research Infrastructure

The READY-PV project consortium of research infrastructures (Reliability Evaluation Through Analytics and Data for Emerging Technology in Photovoltaics) opened its first call for Transnational Access (TA = on-site) and Virtual Access (VA = remote), providing the European photovoltaic research community with free-of-charge access to an integrated...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.